What are you
looking for?

Back to API portfolio search

Buprenorphine HCl


General information

Buprenorphine HCl is the hydrochloride salt form of buprenorphine, which belongs to the class of organic compounds known as morphinans. Buprenorphine is indicated for the treatment of opioid dependence, moderate to severe pain and peri-operative analgesia. It prevents symptoms of withdrawal from opiates such as heroin and is preferred for the induction phase of treatment (conducted under medical supervision). It is considered to be better tolerated without naloxone during the first days of treatment. Following induction, buprenorphine and naloxone are preferred due to the presence of naloxone which impedes intravenous abuse of the product. Buprenorphine HCl can be administered intravenously, as a sublingual tablet, sublingual film or subdermal implant.

Trade names

Suboxone, Buprenex, Subutex, Zubsolv, Bunavail, Temgesic, Bupensan, Bunalict

About the API

Therapeutic areas

Analgesic, opioid addiction

Available grades

Various milled & micronized


USP, Ph. Eur.

Regulatory documentation


DEA schedule


Production location

Zofingen, Pennsville, Minden

Standard pack size

1kg, 5kg, 25kg

Physical properties

White or almost white crystalline powder

Typical formulation types

Oral Solid, injectable

To top